Introduction: Two next-generation pneumococcal conjugate vaccines (PCVs), a 15- and a 20-valent PCV (PCV15 and PCV20), have recently been licensed for use in adults (PCV15: EC decision Oct 14, 2021; PCV20: EC decision Feb 14, 2022). We developed a dynamical transmission model specific for Germany,...